Flibanserin is a breakthrough. We will finally be able to talk to women with hypoactive sexual desire disorder about a treatment that has FDA approval.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.